policy
Canine hybrids
The AVMA strongly opposes keeping as pets any hybrids of wild canines crossbred with domestic animals. The AVMA believes that commercial traffic in…
policy
Development of emerging disease agent biologics
Development of emerging infectious disease biologics is essential for One Health. The AVMA supports the development of these products through…
policy
Embryo transfer and advanced reproductive technology procedures
Embryo transfer and advanced reproductive technology procedures demand a licensed veterinarian's extensive knowledge in anatomy, physiology,…
policy
Guidelines for use of autogenous biologics
Autogenous biological products may provide veterinarians a unique opportunity for control of certain infectious diseases when USDA-licensed commercial…
policy
Inherited disorders in responsible breeding of companion animals
The AVMA encourages careful consideration of the health and welfare implications of breed standards, breeding decisions, and the responsibilities…
policy
National Animal Health Laboratory Network (NAHLN) funding
The AVMA advocates for funding to develop and maintain infrastructure for a comprehensive National Animal Health Laboratory Network so that the U.S.…
policy
Regenerative medicine, including therapeutic use of stem cells
Regenerative medicine holds promise in treating a variety of diseases, yet questions remain. The AVMA supports the continued scientific development of…